Abstract
Objective: A new class of ethylene/propylene-1H-1,2,3-triazole-4-methylene-tethered isatincoumarin hybrids 8a-j, integrating three anti-tuberculosis pharmacophores coumarin, isatin and 1,2,3- triazole was designed and synthesized.
Method: These hybrids were assessed for their in vitro anti-TB activity against MTB H37Rv and MDRTB, as well as anti-bacterial activity against Gram-positive and Gram-negative strains, and cytotoxicity in VERO cell line.
Results: The results showed that all hybrids with acceptable cytotoxicity (CC50: 64-512 µg/mL) exhibited weak to moderate anti-microbial activity. The most active hybrid 8i with MIC of 50 µg/mL against MTB H37Rv and MDR-TB, also has excellent cytotoxicity profile (CC50: 128 µg/mL).
Conclusion: The resistance index of hybrid 8i was 1, indicating that hybrid 8i has no cross-resistance with the first-line anti-TB agent. Thus, hybrid 8i could act as a lead for further optimization.
Keywords: Coumarin, 1, 2, 3-triazoleisatin, Hybrid compounds, Anti-bacterial, Anti-tuberculosis activity, Structure-activity relationship.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Design, Synthesis and In Vitro Anti-microbial Evaluation of Ethylene/ Propylene-1H-1,2,3-Triazole-4-Methylene-tethered Isatin-coumarin Hybrids
Volume: 17 Issue: 29
Author(s): Xiaohong Jin, Yan Xu , Xuhong Yang, Xiuling Chen , Minghu Wu*, Jianguo Guan and Lianshun Feng
Affiliation:
- School of Nuclear Technology and Chemistry & Life Science, Hubei University of Science and Technology, Xianning,China
Keywords: Coumarin, 1, 2, 3-triazoleisatin, Hybrid compounds, Anti-bacterial, Anti-tuberculosis activity, Structure-activity relationship.
Abstract: Objective: A new class of ethylene/propylene-1H-1,2,3-triazole-4-methylene-tethered isatincoumarin hybrids 8a-j, integrating three anti-tuberculosis pharmacophores coumarin, isatin and 1,2,3- triazole was designed and synthesized.
Method: These hybrids were assessed for their in vitro anti-TB activity against MTB H37Rv and MDRTB, as well as anti-bacterial activity against Gram-positive and Gram-negative strains, and cytotoxicity in VERO cell line.
Results: The results showed that all hybrids with acceptable cytotoxicity (CC50: 64-512 µg/mL) exhibited weak to moderate anti-microbial activity. The most active hybrid 8i with MIC of 50 µg/mL against MTB H37Rv and MDR-TB, also has excellent cytotoxicity profile (CC50: 128 µg/mL).
Conclusion: The resistance index of hybrid 8i was 1, indicating that hybrid 8i has no cross-resistance with the first-line anti-TB agent. Thus, hybrid 8i could act as a lead for further optimization.
Export Options
About this article
Cite this article as:
Jin Xiaohong , Xu Yan , Yang Xuhong, Chen Xiuling, Wu Minghu *, Guan Jianguo and Feng Lianshun , Design, Synthesis and In Vitro Anti-microbial Evaluation of Ethylene/ Propylene-1H-1,2,3-Triazole-4-Methylene-tethered Isatin-coumarin Hybrids, Current Topics in Medicinal Chemistry 2017; 17 (29) . https://dx.doi.org/10.2174/1568026618666171215102031
DOI https://dx.doi.org/10.2174/1568026618666171215102031 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
<i>In Vitro</i> Evaluation of Immunogenicity of Recombinant OMP25 Protein Obtained from <i>Endemic Brucella</i> abortus Biovar 3 as Vaccine Candidate Molecule Against Animal Brucellosis
Protein & Peptide Letters Synthesis and Evaluation of Antimicrobial Activity of Thiazolidinone Derivatives
Letters in Drug Design & Discovery Association of Pharmacokinetic and Pharmacodynamic Aspects of Linezolid with Infection Outcome
Current Drug Metabolism An Overview of the Selectivity and Efficiency of the Bacterial Carbonic Anhydrase Inhibitors
Current Medicinal Chemistry A Virtual Screening Approach for the Identification of High Affinity Small Molecules Targeting BCR-ABL1 Inhibitors for the Treatment of Chronic Myeloid Leukemia
Current Topics in Medicinal Chemistry Inhibitory MHC Class I Receptors on Myeloid Cells
Current Immunology Reviews (Discontinued) Preface
Recent Patents on Anti-Infective Drug Discovery Antioxidants and Neuroprotection in the Adult and Developing Central Nervous System
Current Medicinal Chemistry The Metabolism and Toxicity of Quinones, Quinonimines, Quinone Methides, and Quinone-Thioethers
Current Drug Metabolism Ibalizumab-Human CD4 Receptor Interaction: Computational Alanine Scanning Molecular Dynamics Studies
Current Computer-Aided Drug Design Synthesis of 99mTc-Rifabutin: A Potential Tuberculosis Radiodiagnostic Agent
Infectious Disorders - Drug Targets The Multifaceted Activities of Mammalian Defensins
Current Pharmaceutical Design A Note on the Potential BCG Vaccination – COVID-19 Molecular Link
Coronaviruses Ester of Quinoxaline-7-carboxylate 1,4-di-N-oxide as Apoptosis Inductors in K-562 Cell Line: An in vitro, QSAR and DFT Study
Anti-Cancer Agents in Medicinal Chemistry Tackling Drug-Resistant Tuberculosis: Current Trends and Approaches
Mini-Reviews in Medicinal Chemistry Repurposing Drugs to Combat Drug Resistance in Leprosy: A Review of Opportunities
Combinatorial Chemistry & High Throughput Screening Medicolegal Aspects of Disclosure of Side Effects of Biologic Drugs in Rheumatology: A Pilot Study
New Emirates Medical Journal Radical Releasing Anti-tuberculosis Agents and the Treatment of <i>Mycobacterial Tuberculosis</i> Infections - An Overview
Mini-Reviews in Medicinal Chemistry Breath Tests in Diagnosis of Pulmonary Tuberculosis
Recent Patents on Biotechnology Graphical Abstracts:
Letters in Drug Design & Discovery